Literature DB >> 2949890

Platelet accumulation in experimental angioplasty: time course and relation to vascular injury.

J R Wilentz, T A Sanborn, C C Haudenschild, C R Valeri, T J Ryan, D P Faxon.   

Abstract

Since platelet accumulation may be an important determinant of restenosis after angioplasty, the time course of 51Cr-labeled platelet accumulation after experimental angioplasty was evaluated in a deendothelialized, hypercholesterolemic rabbit preparation of atherosclerosis. Marked platelet accumulation (39.5 +/- 8.7 X 10(6) platelets/1 cm vessel length) was observed at 30 min and remained active until 4 hr after angioplasty. Total accumulation over 24 hr was 56.4 +/- 4.7 X 10(6) platelets/1 cm length. Histologic dissection was directly related to the degree of platelet accumulation, with 64 +/- 15 X 10(6) platelets/1 cm in the group with marked dissection and 8.7 +/- 3.7 X 10(6) platelets/1 cm in the group with minimal dissection (p less than .05). Increasing angiographic dissection also resulted in a trend toward increased platelet accumulation, and angiographic change in luminal diameter showed a significant correlation with platelet accumulation. It is concluded that marked platelet accumulation occurs early after transluminal angioplasty and is related to the extent of dissection. Restenosis may result from a complex interaction of platelet accumulation, vascular damage, and blood flow.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2949890     DOI: 10.1161/01.cir.75.3.636

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  24 in total

Review 1.  Antithrombotic therapy in the cardiac catheterization laboratory: focus on antiplatelet agents.

Authors:  M I Furman; A L Frelinger III; A D Michelson
Journal:  Curr Cardiol Rep       Date:  2000-09       Impact factor: 2.931

2.  Detection of arterial thrombosis after laser angioplasty by platelet scintigraphy.

Authors:  S R Mohan; R J Hawker; A P Wolinski; R P Grimley
Journal:  Eur J Nucl Med       Date:  1990

Review 3.  Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the Holy Grail? (Part II).

Authors:  J P Herrman; W R Hermans; J Vos; P W Serruys
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

4.  Ultrastructural characteristics of cellular reaction after experimentally induced lesions in the arterial vessel.

Authors:  P Gonschior; F Gerheuser; H A Lehr; U Welsch; B Höfling
Journal:  Basic Res Cardiol       Date:  1995 Mar-Apr       Impact factor: 17.165

Review 5.  Perspectives on the future of platelet glycoprotein IIb/IIIa blockade therapy.

Authors:  J E Tcheng
Journal:  Tex Heart Inst J       Date:  1998

Review 6.  Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics.

Authors:  B S Coller
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

7.  Tissue factor is rapidly induced in arterial smooth muscle after balloon injury.

Authors:  J D Marmur; M Rossikhina; A Guha; B Fyfe; V Friedrich; M Mendlowitz; Y Nemerson; M B Taubman
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

8.  High frequency rotational ablation: an alternative in treating coronary artery stenoses and occlusions.

Authors:  U Dietz; R Erbel; H J Rupprecht; S Weidmann; J Meyer
Journal:  Br Heart J       Date:  1993-10

Review 9.  Modulating thrombotic potential in catheter-based percutaneous coronary and peripheral vascular interventions.

Authors:  James L Orford; Peter B Berger
Journal:  J Thromb Thrombolysis       Date:  2004-02       Impact factor: 2.300

10.  Pharmacological prevention of peri-, and post-procedural myocardial injury in percutaneous coronary intervention.

Authors:  Hideki Ishii; Tetsuya Amano; Tatsuaki Matsubara; Toyoaki Murohara
Journal:  Curr Cardiol Rev       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.